 |
|
|
| |
Dolutegravir + Lamivudine in People With HIV-1 Who Are Naive to Antiretroviral Therapy With Baseline Viral Load ≥500,000 c/mL: Systematic Literature Review and Meta-Analysis of Real-World Evidence
|
| |
| |
IDSA 2026 October 21-24 Wash DC
John Boulos,1 Kyana Stewart,1 Eva Fernvik,2 Piotr Budnik,3 Emilio Letang4
1ViiV Healthcare, Durham, NC, USA; 2ViiV Healthcare, Stockholm, Sweden; 3ViiV Healthcare, London, UK; 4ViiV Healthcare, Tres Cantos, Madrid, Spain
|
| |
|
|
|
|
|
